andexanet alfa
Generic: andexanet alfa·Brand: Andexxa
andexanet alfa: 2 clinical trials tracked.
andexanet alfa evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about andexanet alfa, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (2)
A Phase I, Randomized, Single-blind, Placebo-controlled Study to Further Characterize Andexanet Posology and Assess the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
Primary endpoint: Anti-Factor (F) Xa activity
InterventionalRandomizedsingle191 enrolledStarted 2026-01Completion 2026-062 sites · Germany, United KingdomAstraZeneca
Retrospective Real World Evidence Study to Describe Characteristics and Outcomes in Dutch Patients Admitted to the Hospital With a Factor Xa Inhibitor-associated Bleeding Treated With Andexanet Alfa
Primary endpoint: Patient characteristics
Observational217 enrolledStarted 2023-10Completion 2025-111 site · NetherlandsAstraZeneca